Litcius/Paper detail

Tiragolumab and atezolizumab in patients with PD-L1 positive non-small-cell lung cancer

Gonzalo Recondo, Laura Mezquita

2022The Lancet Oncology23 citationsDOI

Topics & Concepts

PembrolizumabAtezolizumabMedicinePemetrexedLung cancerOncologyInternal medicineChemotherapyPD-L1Thymidylate synthaseCancerImmunotherapyCisplatinFluorouracilCancer Immunotherapy and BiomarkersPeptidase Inhibition and AnalysisLung Cancer Research Studies
Tiragolumab and atezolizumab in patients with PD-L1 positive non-small-cell lung cancer | Litcius